Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue SUPPL. 3, 2012, Pages 22-31

  Archier, E ^a   Devaux, S ^b   Castela, E ^c   Gallini, A ^d   Aubin, F ^e   Le Maitre M ^f   Aractingi, S ^g   Bachelez, H ^h   Cribier, B ⁱ   Joly, P ^j   Jullien, D ^k   Misery, L ^l   Paul, C ^b   Ortonne, J P ^c   Richard, M A ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

^d Faculté de Médecine Centre Hospitalo universitaire   (France)

^e UNIVERSITY HOSPITAL OF BESANÇON   (France)

^f Saint Louis Hospital ^*

^g HÔPITAL TENON   (France)

^h SAINT LOUIS HOSPITAL   (France)

ⁱ UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^j UNIVERSITÉ DE ROUEN   (France)

^k EDOUARD HERRIOT HOSPITAL   (France)

^l BREST UNIVERSITY HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

METHOXSALEN;

BASAL CELL CARCINOMA; CANCER RISK; CARCINOGENESIS; FOLLOW UP; HUMAN; MEDICAL LITERATURE; MELANOMA; MERKEL CELL TUMOR; PENIS TUMOR; PRIORITY JOURNAL; PSORIASIS; PUVA; REVIEW; SKIN CANCER; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

CHRONIC DISEASE; FEMALE; HUMANS; MALE; METHOXSALEN; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PSORIASIS; RISK ASSESSMENT; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 84860113472     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04520.x     Document Type: Review

References (66)

1. Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA,. Photochemo-therapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 1974; 291: 1207-1211.
2. Dunnick JK, Forbes PD, Eustis SL, et al. Tumors of the skin in the HRA/Skh mouse after treatment with 8-methoxypsoralen and UVA radiation. Fundam Appl Toxicol 1991; 16: 92-102.
3. van der Leun JC, vanWeelden H,. UV-B phototherapy: principles, radiation sources, regimens. Curr Probl Dermatol 1986; 15: 39-51.
4. Archier E, Devaux S, Castela E, et al. Efficacy of Psoralen UV-A therapy vs Narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. JEADV (this issue).
5. El-Ghorr AA, Norval M,. Biological effects of narrow- band (311nm TL01) UVB irradiation: a review. J Photochem Photobiol, B 1997; 38: 99-106. (Pubitemid 27277864)
6. Wulf HC, Hansen AB, Bech-Thomsen N,. Differences in narrowband ultraviolet-B and broadspectrum ultraviolet photocarcinogenesis in lightly pigmented hairless mice. Photoderm Photoimmunol Photomed 1994; 10: 192-197. (Pubitemid 24357434)
7. Young A,. Carcinogenicity of UVB phototherapy assessed. Lancet 1995; 345: 1431-1432.
8. Paul C, Gallini A, Archier E, et al. Evidence-based recommendations on topical treatment and phototherapy of psoriasis: systematic review and expert opinion of a panel of dermatologists. JEADV (this issue).
9. Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, Bleich HL,. Cutaneous squamous-cell carcinoma in patients treated with PUVA. N Engl J Med 1984; 310: 1156-1161. (Pubitemid 14135391)
10. Stern RS, Lange R,. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol 1988; 91: 120-124.
11. Stern RS,. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study. N Engl J Med 1990; 322: 1093-1097. (Pubitemid 20149525)
12. Stern RS, Laird N,. The carcinogenic risk of treatments for severe psoriasis. Cancer 1994; 73: 2759-2764. (Pubitemid 24166263)
13. Stern RS, Liebman EJ, Vakeva L,. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of non-melanoma skin cancer. PUVA Follow-up Study. J Natl Cancer Inst 1998; 90: 1278-1284. (Pubitemid 28433472)
14. Katz KA, Marcil I, Stern RS, et al. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients. J Invest Dermatol 2002; 118: 1038-1043. (Pubitemid 34639184)
15. Stern RS, Bagheri S, Nichols K, et al. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis. J Am Acad Dermatol 2002; 47: 33-39.
16. Nijsten TE, Stern RS,. Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study. J Am Acad Dermatol 2003; 49: 644-650. (Pubitemid 37210277)
17. Hönigsmann H, Wolff K, Gschnait F, et al. Keratoses and nonmelanoma skin tumors in long-term photochemotherapy (PUVA). J Am Acad Dermatol 1980; 3: 406-414. (Pubitemid 11219519)
18. Henseler T, Christophers E,. Risk of skin tumors in psoralen- and ultraviolet A-treated patients. Natl Cancer Inst Monogr 1984; 66: 217-219. (Pubitemid 15157784)
19. Henseler T, Christopher E, Hönigsmann H, et al. Skin tumors in the European PUVA study. J Am Acad Dermatol 1987; 16: 108-111.
20. Cox NH, Jones SK, Downey DJ, et al. Cutaneous and ocular side-effects of oral photochemotherapy: results of an 8-year follow-up study. Br J Dermatol 1987; 116: 145-152. (Pubitemid 17008240)
21. Halprin KM, Comerford M, Taylor JR, et al. Cancer in patients with psoriasis. J Am Acad Dermatol 1982; 7: 633-638. (Pubitemid 12000530)
22. Roenigk HH Jr, Caro WA,. Skin cancer in the PUVA-48 cooperative study. J Am Acad Dermatol 1981; 4: 319-324. (Pubitemid 11115520)
23. Leone GA, Shelk JL,. Photochemotherapy (PUVA) and skin cancer. J Am Acad Dermatol 1985; 13: 155-157.
24. Forman AB, Roenigk HH Jr, Caro WA, et al. Long-term follow-up of skin cancer in the PUVA-48 cooperative study. Arch Dermatol 1989; 125: 515-519. (Pubitemid 19108963)
25. Chuang TY, Tse J, Cripps DJ, et al. A preliminary study on the link between PUVA and skin cancer. Int J Dermatol 1989; 28: 438-440.
26. Perkins W, Lamont D, MacKie RM,. Cutaneous Malignancy in Males Treated with Photochemotherapy. Lancet. 1990 Nov 17; 336 (8725): 1248.
27. Chuang TY, Heinrich LA, Schultz MD, et al. PUVA and skin cancer. A historical cohort study on 492 patients. J Am Acad Dermatol 1992; 26: 173-177.
28. Lassus A, Reunala T, Idänpää-Heikkilä J, et al. PUVA treatment and skin cancer: A follow-up study. Acta Derm Venereol (Stockh) 1981; 61: 141-145. (Pubitemid 11147562)
29. Lobel E, Paver K, King R, et al. The relationship of skin cancer to PUVA therapy in Australia. Australas J Dermatol 1981; 22: 100-103. (Pubitemid 12078421)
30. Lindskov R,. Skin carcinomas and treatment with photochemotherapy. Acta Derm Venereol (Stockh) 1983; 63: 223-226.
31. Ros AM, Wennersten G, Lagerholm B, et al. Long-term photochemotherapy for psoriasis: a histopathological and clinical follow-up study with special emphasis on tumour incidence and behavior of pigmented lesions. Acta Derm Venereol (Stockh) 1983; 63: 215-221. (Pubitemid 13094641)
32. Reshad H, Challoner F, Pollock DJ, et al. Cutaneous carcinoma in psoriatic patients treated with PUVA. Br J Dermatol 1984; 110: 299-305. (Pubitemid 14155647)
33. Eskelinen A, Halme K, Lassus A, et al. Risk of cutaneous carcinoma in psoriatic patients treated with PUVA. Photodermatol 1985; 2: 10-14. (Pubitemid 15173425)
34. Torinuki W, Tagami H,. Incidence of skin cancer in Japanese psoriatic patients treated with either methoxsalen phototherapy, Goeckerman regimen, or both therapies. A 10-year follow up study. J Am Acad Dermatol 1988; 18: 1278-1281.
35. Tanew A, Hönigsmann H, Ortel B, et al. Nonmelanoma skin tumors in long-term photochemotherapy treatment of psoriasis. An 8-year follow-up study. J Am Acad Dermatol 1986; 15: 960-965. (Pubitemid 17176808)
36. Abdullah AN, Keczkes K,. Cutaneous and ocular side-effects of PUVA photochemotherapy-a 10-year follow-up study. Clin Exp Dermatol 1989; 14: 421-424. (Pubitemid 19278987)
37. BruynzeelI I, Bergman W, Hartevelt HM, et al. 'High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer. Br J Dermatol 1991; 124: 49-55.
38. Lindelöf B, Sigurgeirsson B, Tegner E, et al. PUVA and cancer: a large-scale epidemiological study. Lancet 1991; 338: 391-393.
39. Mali-Gerrits MG, Gaasbeek D, Boezeman J, et al. Psoriasis therapy and the risk of skin cancers. Clin Exp Dermatol 1991; 16: 85-89.
40. Lindelöf B, Sigurgeirsson B, Tegner E, et al. Comparison of the carcinogenic potential of trioxsalen bath PUVA and oral methoxsalen PUVA. Arch Dermatol 1992; 128: 1341-1344.
41. Lever LR, Farr PM,. Skin cancers or premalignant lesions occur in half of high-dose PUVA patients. Br J Dermatol 1994; 131: 215-219. (Pubitemid 24251494)
42. McKenna KE, Patterson CC, Handley J, et al. Cutaneous neoplasia following PUVA therapy for psoriasis. Br J Dermatol 1996; 134: 639-642. (Pubitemid 26120731)
43. Gritiyarangsan P, Sindhavananda J, Rungrairatanaroj P, et al. Cutaneous carcinoma and PUVA lentigines in Thai patients treated with oral PUVA. Photodermatol Photoimmunol Photomed 1995; 11: 174-177. (Pubitemid 26005539)
44. Maier H, Schemper M, Ortel B, et al. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients. Dermatology 1996; 193: 185-191. (Pubitemid 26361518)
45. Cockayne SE, August PJ,. PUVA photocarcinogenesis in Cheshire. Clin Exp Dermatol 1997; 22: 300-301.
46. Lindelöf B, Sigurgeirsson B, Tegner E, et al. PUVA and cancer risk: the Swedish follow-up study. Br J Dermatol 1999; 141: 108-112. (Pubitemid 29333701)
47. Hannuksela-Svahn A, Pukkala E, Läärä E, et al. Psoriasis, its treatment, and cancer in a cohort of Finnish Patients. J Invest Dermatol 2000; 114: 587-590. (Pubitemid 30415349)
48. Aubin F, Puzenat E, Arveux P, et al. Genital squamous cell carcinoma in men treated by photochemotherapy. A cancer registry-based study from 1978 to 1998. Br J Dermatol 2001; 144: 1204-1206. (Pubitemid 34204212)
49. Raiss M, Templier I, Beani JC, et al. PUVAthérapie et cancers cutanés. Etude rétrospective chez 106 malades ayant reçu des doses élevées de PUVA. Ann Dermatol Venereol 2004; 131: 437-443. (Pubitemid 38796809)
50. Gupta AK, Stern RS, Swanson NA, Anderson TF,. Cutaneous melanomas in patients treated with psoralens plus ultraviolet A. A case report and the experience of the PUVA follow-up study. J Am Acad Dermatol 1988; 19: 67-76.
51. Stern RS, Nichols KT, Väkevä LH,. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA follow-up study. N Engl J Med 1997; 336: 1041-1045. (Pubitemid 27163855)
52. Stern RS,. PUVA follow up study. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol. 2001; 44: 755-761.
53. Lunder EJ, Stern RS,. Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation. N Engl J Med 1998; 339: 1247-1248. (Pubitemid 28482140)
54. Weischer M, Blum A, Eberhard F, et al. No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study. Acta Derm Venereol 2004; 84: 370-374. (Pubitemid 39312270)
55. Man I, Crombie IK, Dawe RS, et al. The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data. Br J Dermatol 2005; 152: 755-757. (Pubitemid 40571310)
56. Black RJ, Gavin AT,. Photocarcinogenic risk of narrowband ultraviolet B (TL-01) phototherapy: early follow-up data. Br J Dermatol 2006; 154: 566-567. (Pubitemid 43382678)
57. Hearn RM, Kerr AC, Rahim KF, et al. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. Br J Dermatol 2008; 159: 931-935.
58. Stern RS, Lunder EJ,. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis. Arch Dermatol 1998; 134: 1582-1585. (Pubitemid 29009260)
59. Heath M, Jaimes N, Lemos B, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol 2008; 58: 375-381. (Pubitemid 351226308)
60. Feng H, Shuda M, Chang Y, Moore PS,. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319: 1096-1100. (Pubitemid 351300792)
61. Misery L, Boulais N,. Le carcinome de Merkel est-il une maladie virale? Ann Dermatol Venereol 2008; 135: 503-504.
62. Schmutz JL, Jeanmougin M, Martin S, et al. Recommandations de la société française de photodermatologie pour la PUVAthérapie systémique dans le psoriasis vulgaire. Ann Dermatol Venereol 2000; 127: 73-79.
63. Beani JC, Jeanmougin M,. Photothérapie UVB à spectre étroit dans le psoriasis vulgaire: utilisation pratique et préconisations de la société française de photodermatologie. Ann Dermatol Venereol 2010; 137: 21-31.
64. Ibbotson SH, Bilsland D, Cox NH, et al. An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report. Br J Dermatol 2004; 151: 283-297. (Pubitemid 39215142)
65. Menter A, Korman NJ, Elmets CA, et al., Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol 2010; 62: 114-135.
66. Diffey BL,. Factors affecting the choice of a ceiling on the number of exposures with TL01 ultraviolet B phototherapy. Br J Dermatol 2003; 149: 428-430. (Pubitemid 37100282)